Clinical Trials Browser

Phase 2 × Metastatic Urothelial Cancer × Carboplatin × Clear all

NCT03547973 2026-03-16

TROPHY U-01

Phase 2 Recruiting

827 enrolled 1 FDA

Metastatic Urothelial Cancer

NCT03451331 2024-05-16

Gemcitabine + Carboplatin + Nivolumab Versus Gemcitabine + Oxaliplatin + Nivolumab in Cisplatin-ineligible Patients With Metastatic Urothelial Cancer

Phase 2 Completed

49 enrolled 15 charts

Metastatic Urothelial Cancer